Advertisement

Topics

AdvaMed comments on FDA's "least burdensome" guidance

06:21 EDT 13 Mar 2018 | SmartBrief

AdvaMed submitted comments to the FDA regarding the draft guidance on the "least burdensome" concept, asking the agency to pr -More

Original Article: AdvaMed comments on FDA's "least burdensome" guidance

NEXT ARTICLE

More From BioPortfolio on "AdvaMed comments on FDA's "least burdensome" guidance"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...